Indivior的动态

Pharmacists, you can take the lead in improving access to treatment for opioid use disorder! Join policy expert Tyler Varisco, PharmD, PhD, to examine the groundbreaking PhARM-OUD Guidelines developed by NCPA and the National Association of Boards of Pharmacy. These consensus, evidence-based practice guidelines were created to help overcome challenges and clear up confusion so that you can stock buprenorphine in your pharmacy and safely and effectively dispense this essential medication. Register for this webinar, taking place Nov. 14 at 2 p.m. ET, and discover how you can bring real change to your practice and your community. https://bit.ly/3Nl1YJy This webinar is sponsored by the Foundation for Opioid Response Efforts.

CASE STUDY—We helped a client determine the human abuse potential of their novel neuropathic pain medication with a multi-study program, delivering robust data for their regulatory submissions. We review this study on our blog. Read it here: https://lnkd.in/dsjgbsQy #DrugDevelopment #ClinicalTrials #Analgesic

I've been featured in an article on Patient.info, discussing treatment options for labyrinthitis. Labyrinthitis can be a challenging condition, but understanding ways to manage symptoms can help bring relief to many. Read more in the full article: https://lnkd.in/ec9PcSK9 Thank you to the team at Patient.info for this opportunity! #Labyrinthitis #Pharmacy #PatientCare #HealthAndWellbeing?

It was a pleasure being part of the trio (with Suzanne Nielsen & Louisa Picco) writing this November Australian Journal of Pharmacy article (link below) about the new Opioid Safety Toolkit - a super valuable resource which supports the monitoring of opioid-related clinical outcomes and aims to increase opioid health literacy, to enhance safer use of prescription opioids and reduce opioid-related harms. Pharmacists and other healthcare professionals can support their patients to use the toolkit, improve their clinical outcomes, develop an opioid safety plan, and understand the vital role of naloxone in being prepared for potential opioid-related adverse events or toxicity. Link to article below, and check out the Opioid Safety Toolkit here ???? saferopioiduse.com.au.

Today is International #OverdoseAwarenessDay. Take a moment to learn about #naloxone – a medicine that rapidly reverses an opioid overdose – and share it with family members, students, or colleagues. It could #SaveALife. Learn more at https://ow.ly/P1B350T9O7a #OpioidCrisis #AddictionRecovery #EndTheStigma #TeamNCDAC

The official release of Sam - the first and only digital companion for steroid-treated patients - will commence in one hour. Save your spot to be part of this exciting moment in clinical history: https://hubs.li/Q02CJZ990 #SteroidsandMe #SteroidToxicity #PatientEducation #PatientOutcomes #PatientAdvocacy #HealthOutcomes

The official release of Steroids and Me - the first and only digital companion for steroid-treated patients - will commence in one hour. Save your spot to be part of this exciting moment in clinical history: https://hubs.li/Q02CK9kg0 #SteroidsandMe #SteroidToxicity #PatientEducation #PatientOutcomes #PatientAdvocacy #HealthOutcomes

Are you ready to end the opioid crisis? This book has solutions. Join me and world-class healthcare leaders from the Mayo Clinic Opioid Stewardship program as we demystify pain, discuss when and how opioids can be used safely, and outline how to navigate through their complications. Written for patients, care-givers and the medical community, this book demystifies the epidemic and brings tangible solutions into your home and practice. #opioids #addiction #opioidusedisorder #mayoclinic

The time for Opioid Stewardship is Today! Listen in as I join the AHA in a 5 part series discussing how your healthcare center can develop its own Opioid Stewardship Program. It's time we give the right drug to the right patient for the right indication at the right dose for the right length of treatment and navigate opioid-related complications with the right treatments. #opioidstewardship #opioids #addiction https://lnkd.in/eQYPYVh5

If you’re not using Irix? Medical Data and Prescription Data to assess?mortality #risk in multi-use drug cases, you could be missing major red flags or major opportunities. Join Matt Glasow at the Alabama Home Office Underwriters and Claims Association (AHOUCA) meeting, May 16, to learn how to use these #insurtech tools to instantly differentiate between common, benign neurological conditions and a range of more serious concerns including mental health and even cardiac issues.?#underwriting